| Financial Year |
March 31 2023 |
| Monetary Funds |
379,827,458.88 |
| Held-for-trading Financial Assets |
41,944,416.69 |
| Notes Receivable |
82,626,320.58 |
| Accounts Receivable |
1,562,142,095.73 |
| Advances to Suppliers |
117,163,285.39 |
| Other Receivables |
95,707,416.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
29,227,795.66 |
| Dividend Receivable |
1,106,597.66 |
| Inventories |
1,548,791,462.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
55,171,609.00 |
| Other Current Assets |
202,008,909.55 |
| Total Current Assets |
4,173,012,891.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
545,619,640.09 |
| Long-term Equity Investment |
219,702,629.96 |
| Investment Properties |
85,799,029.10 |
| Fixed Assetes |
1,263,429,201.65 |
| Under-construction Projects |
540,619,355.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
410,764,683.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,768,977.19 |
| Deferred Income Tax Assets |
68,421,127.65 |
| Other Non-Current Assets |
1,114,424,094.00 |
| Sub-Total of Non-Current Assets |
4,257,347,610.42 |
| Total Assets |
8,430,360,501.68 |
| Short-Term Loans |
437,083,727.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,477,359,942.90 |
| Accounts Payable |
1,188,418,040.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,843,494.91 |
| Taxes Payable |
9,749,406.81 |
| Interest Payable |
11,571,407.51 |
| Dividend Payable |
-- |
| Other payables |
63,943,108.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
316,749,109.69 |
| Other Current Liabilities |
51,327,776.42 |
| Sub-Total of Current Liabilities |
3,862,194,854.84 |
| Long-term Loans |
644,200,000.00 |
| Bonds Payable |
806,759,329.98 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,366,222.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,525,046,755.68 |
| Total Liabilities |
5,387,241,610.52 |
| Paid-In Capital(Or Share Stock) |
435,973,215.00 |
| Capital Surplus |
388,170,029.62 |
| Surplus Reserve |
261,926,771.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,628,507,711.80 |
| Minority Stockholder's Interest |
220,183,796.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,822,935,094.54 |
| Owner's Equity（Stockholder's Equity） |
3,043,118,891.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,430,360,501.68 |
